RAPID NUTRITION PLC (ALRPD.PA) Fundamental Analysis & Valuation

EPA:ALRPD • GB00BVVK7R18

10.9 EUR
+0.1 (+0.94%)
Last: Feb 17, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This ALRPD.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALRPD. ALRPD was compared to 64 industry peers in the Food Products industry. ALRPD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALRPD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. ALRPD.PA Profitability Analysis

1.1 Basic Checks

  • ALRPD had negative earnings in the past year.
  • ALRPD had negative earnings in 4 of the past 5 years.
  • ALRPD had a negative operating cash flow in each of the past 5 years.
ALRPD.PA Yearly Net Income VS EBIT VS OCF VS FCFALRPD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -108.16%, ALRPD is doing worse than 96.61% of the companies in the same industry.
  • With a Return On Equity value of -155.52%, ALRPD is not doing good in the industry: 93.22% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -108.16%
ROE -155.52%
ROIC N/A
ROA(3y)-313.12%
ROA(5y)-229.77%
ROE(3y)-1380.41%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALRPD.PA Yearly ROA, ROE, ROICALRPD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

  • The Gross Margin of ALRPD (74.23%) is better than 100.00% of its industry peers.
  • In the last couple of years the Gross Margin of ALRPD has declined.
  • The Profit Margin and Operating Margin are not available for ALRPD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.21%
GM growth 5Y-4.48%
ALRPD.PA Yearly Profit, Operating, Gross MarginsALRPD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ALRPD.PA Health Analysis

2.1 Basic Checks

  • ALRPD has more shares outstanding than it did 1 year ago.
  • ALRPD has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ALRPD has been reduced compared to a year ago.
ALRPD.PA Yearly Shares OutstandingALRPD.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALRPD.PA Yearly Total Debt VS Total AssetsALRPD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

  • ALRPD has an Altman-Z score of -16.09. This is a bad value and indicates that ALRPD is not financially healthy and even has some risk of bankruptcy.
  • ALRPD has a Altman-Z score of -16.09. This is amonst the worse of the industry: ALRPD underperforms 86.44% of its industry peers.
  • A Debt/Equity ratio of 0.05 indicates that ALRPD is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.05, ALRPD belongs to the top of the industry, outperforming 88.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z -16.09
ROIC/WACCN/A
WACCN/A
ALRPD.PA Yearly LT Debt VS Equity VS FCFALRPD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

  • A Current Ratio of 3.57 indicates that ALRPD has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 3.57, ALRPD belongs to the best of the industry, outperforming 89.83% of the companies in the same industry.
  • ALRPD has a Quick Ratio of 2.78. This indicates that ALRPD is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of ALRPD (2.78) is better than 91.53% of its industry peers.
Industry RankSector Rank
Current Ratio 3.57
Quick Ratio 2.78
ALRPD.PA Yearly Current Assets VS Current LiabilitesALRPD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ALRPD.PA Growth Analysis

3.1 Past

  • ALRPD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 96.68%, which is quite impressive.
  • The Revenue for ALRPD has decreased by -41.11% in the past year. This is quite bad
  • The Revenue for ALRPD have been decreasing by -21.65% on average. This is quite bad
EPS 1Y (TTM)96.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)-41.11%
Revenue growth 3Y-32.65%
Revenue growth 5Y-21.65%
Sales Q2Q%-59.04%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • Based on estimates for the next years, ALRPD will show a quite strong growth in Revenue. The Revenue will grow by 11.70% on average per year.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.21%
Revenue Next 2Y11.21%
Revenue Next 3Y11.7%
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALRPD.PA Yearly Revenue VS EstimatesALRPD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M
ALRPD.PA Yearly EPS VS EstimatesALRPD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

0

4. ALRPD.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALRPD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALRPD.PA Price Earnings VS Forward Price EarningsALRPD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALRPD.PA Per share dataALRPD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALRPD.PA Dividend Analysis

5.1 Amount

  • No dividends for ALRPD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALRPD.PA Fundamentals: All Metrics, Ratios and Statistics

RAPID NUTRITION PLC

EPA:ALRPD (2/17/2026, 7:00:00 PM)

10.9

+0.1 (+0.94%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)05-20
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap5.12M
Revenue(TTM)754.10K
Net Income(TTM)-2.57M
Analysts84.44
Price Target12.75 (16.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2400%
PT rev (3m)2400%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.29
P/FCF N/A
P/OCF N/A
P/B 5.15
P/tB 5.15
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.97
BVpS2.12
TBVpS2.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -108.16%
ROE -155.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.23%
FCFM N/A
ROA(3y)-313.12%
ROA(5y)-229.77%
ROE(3y)-1380.41%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.21%
GM growth 5Y-4.48%
F-ScoreN/A
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.57
Quick Ratio 2.78
Altman-Z -16.09
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-41.11%
Revenue growth 3Y-32.65%
Revenue growth 5Y-21.65%
Sales Q2Q%-59.04%
Revenue Next Year10.21%
Revenue Next 2Y11.21%
Revenue Next 3Y11.7%
Revenue Next 5YN/A
EBIT growth 1Y75.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year58.16%
EBIT Next 3Y42.38%
EBIT Next 5YN/A
FCF growth 1Y-93.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-93.55%
OCF growth 3YN/A
OCF growth 5YN/A

RAPID NUTRITION PLC / ALRPD.PA FAQ

What is the fundamental rating for ALRPD stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALRPD.PA.


Can you provide the valuation status for RAPID NUTRITION PLC?

ChartMill assigns a valuation rating of 0 / 10 to RAPID NUTRITION PLC (ALRPD.PA). This can be considered as Overvalued.


How profitable is RAPID NUTRITION PLC (ALRPD.PA) stock?

RAPID NUTRITION PLC (ALRPD.PA) has a profitability rating of 1 / 10.